Ignite Creation Date:
2025-12-25 @ 4:57 AM
Ignite Modification Date:
2025-12-26 @ 3:56 AM
Study NCT ID:
NCT03438318
Status:
COMPLETED
Last Update Posted:
2022-08-03
First Post:
2018-01-25
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study Evaluating CMP-001 in Combination With Atezolizumab in Participants With Non-Small Cell Lung Cancer
Sponsor:
Regeneron Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-03-15
Start Date Type:
ACTUAL
Primary Completion Date:
2019-12-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-12-11
Completion Date Type:
ACTUAL
First Submit Date:
2018-01-25
First Submit QC Date:
None
Study First Post Date:
2018-02-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-08-01
Last Update Post Date:
2022-08-03
Last Update Post Date Type:
ACTUAL